Genetron Holdings Limited provided revenue guidance for the year 2022. For the year, the company expects revenue guidance to be around RMB 585 million to RMB 638 million, or around 10% to 20% of growth compared to year 2021.
Genetron Holdings Limited
Equities
GTH
US37186H2094
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+2.52% | 42.75B | |
+47.70% | 41.61B | |
+12.06% | 41.34B | |
-8.83% | 26.59B | |
+6.99% | 25.49B | |
-22.61% | 18.12B | |
+30.39% | 12.24B | |
-2.15% | 11.76B | |
+9.12% | 11B |